Bronchial artery embolization in the management of hemoptysis in XXXX .

@entity1 @entity662 @entity4832 @entity548 @entity281 @entity1576 @entity1282 @entity221 @entity1577
Massive hemoptysis and/or recurrent expectoration of measurable amounts of blood are common complications of @entity281 in @entity1577 ( @entity1577 ). When conservative treatment fails to control @entity548 , surgery or bronchial artery embolization (BAE) is frequently considered. We present our experience and long-term follow up of BAE in 14 @entity1577 @entity1 (age range 15-39 years) with massive (6 subjects) and/or recurrent (8 subjects) hemoptysis not responsive to medical treatment. Seven had chronic @entity1576 . After angiographic evaluation, @entity4832 particles (Ivalon) were injected to embolize obviously enlarged bronchial arteries. Seventeen procedures were performed in 14 @entity1 and 36 bronchial arteries were embolized. All the @entity1 stopped @entity548 immediately upon BAE. Most of the @entity1 had postembolization @entity221 , @entity1282 , and transient @entity662 which were managed symptomatically. After a median follow-up period of 10.5 months (range 0.5-38 months), no recurrence of hemoptysis was observed in 8 @entity1 who are still alive. In 3 @entity1 hemoptysis recurred and they underwent reembolization after 3, 22, and 25 months, respectively. Three subjects died of @entity1576 within 5 months from BAE. Presently, 50% of @entity1 studied had a > or = 1 year interval free of major hemoptysis after the first BAE. Our experience indicates that massive and/or recurrent hemoptysis in @entity1577 @entity1 can be safety and effectively managed by BAE if the procedure is performed by a skilled practitioner. The procedure was well tolerated and resulted in prolonged and satisfactory @entity548 control in most @entity1 .
